Newsletter Edition #152 [Treaty Talks]
Readers,
Countries will decide next week on who gets access to medical products during health emergencies, and how preparedness and response are determined in the
Newsletter Edition #151 [Treaty Talks]
Readers,
Developing countries have been pushing for the access to technology to make medical products, to better prepare for, and respond to health emergencies. This
Newsletter Edition #335
[GHF Plus: Global Health Policy Intelligence]
This edition was first published on March 13, 2026.
Readers,
In this edition, we bring you a mapping of pharma litigation
Newsletter Edition #150 [Treaty Talks]
Readers,
In today's edition, we bring you an analysis on biosecurity in the context of the current negotiations on the Pathogen Access Benefit
Newsletter Edition #335
[GHF Plus: Global Health Policy Intelligence]
Readers,
In this edition, we bring you a mapping of pharma litigation in 2025. The idea was to give a snapshot
Newsletter Edition #149 [Treaty Talks]
Readers,
In this edition, we bring you a quick update on new text proposals on the Pathogen Access Benefit Sharing (PABS) System being negotiated at
Newsletter Edition #332 [The Files In-Depth]
Countries’ request for the inclusion of digital health, AI governance and precision medicine on the WHO Executive Board agenda, reflects the growing political urgency.
Newsletter Edition #333 [The Files In-Depth]
Why is this important for global health? Because geopolitics determines everything: from disrupting supply chains for humanitarian aid, to attacks on health facilities; from
Newsletter Edition #332 [The Files In-Depth]
Countries’ request for the inclusion of digital health, AI governance and precision medicine on the WHO Executive Board agenda, reflects the growing political urgency.
Dear Readers,
First and foremost: thank you. Seven thousand of you, across 150 countries, have been reading Geneva Health Files since we launched in 2020. That still amazes us, and
![[EXCLUSIVE] New IGWG Text: Strong Obligations To Share Pathogen Information, Lists Technology Transfer & Licensing As "Optional" Benefits](https://storage.ghost.io/c/3e/27/3e275aa8-3271-4edb-ac7b-04dcacf8a053/content/images/size/w960/format/webp/2026/03/pexels-steve-3518623-1.jpg)
![Leading The World Health Organization: Challenges & Opportunities Ahead For A New Director-General [GUEST ESSAY]](https://storage.ghost.io/c/3e/27/3e275aa8-3271-4edb-ac7b-04dcacf8a053/content/images/size/w960/format/webp/public/images/d7c0b56d-fde9-4a7a-8c06-4fde7dcc07cc_8192x5461.jpg)